MediPharm Labs and Burleigh Head Enters Agreement For a Supply Deal

MediPharm Labs and Burleigh Heads sign a deal to supply cannabis oil.

MediPharm Labs Corp. (TSX: LABS) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce that through its subsidiary MediPharm Labs Australia Pty Ltd, it has entered into a supply agreement for white label pharmaceutical-quality (GMP certified) cannabis oil products with Burleigh Heads Cannabis Pty Ltd.

Under the agreement, which has an initial 3-year term, MediPharm Labs Australia will supply bottles of white labelled, formulated cannabis oil products for distribution by Burleigh Heads.

Burleigh Heads is an Australian wholesaler of medical cannabis products that are distributed to medical patients and pharmacies across Australia via its innovative online CanView marketplace. Burleigh Heads is a subsidiary of CDA Health Pty Ltd, an established Australian business supporting patient access to medical cannabis products in Australia. Through its CDA Clinics, CDA assists doctors and patients in navigating the State and Federal SAS and Authorised Prescriber processes, and provide educational resources and one-to-one service from their consultant doctors through physical and telehealth clinics. Since first launching in October 2018, CDA Clinics has completed over 6,000 successful patient approvals through the Australian Therapeutic Goods Administration.

We are excited to be working with industry leaders like Burleigh Heads and CDA.Warren Everitt, Chief Executive Officer, MediPharm Labs Australia.

"As the number of patients in Australia increase, we are well-positioned to further expand our distribution through various channels and provide a supply of GMP finished products thanks to our international supply chain and the recent TGA GMP certification of our MediPharm Labs Canada facility," Mr. Everitt concluded.

Guy Headley, Director of Operations for CDA says, "We are thrilled to be partnering with MediPharm Labs Australia to bring quality GMP products to our national network of medical professionals, pharmacies and patients.  This is a testament to the progression of the Australian medical cannabis industry's forward movement which will bring an alternative, more affordable option to patients.  We look forward to working closely together with MediPharm Labs into the coming years."

To learn more about Medipharm Labs, visit the company HQ here.

Disclaimer: Past performance is not an indicator of future performance.

Get the Latest Marijuana News &
Content in your Inbox!

All your support helps The Green Fund keep writing content for all you
marijuana enthusiasts and potential pot stock investors

Casey Peternell
Casey Peternell

Casey is a media and content creator with a keen eye for creativity. Casey is currently in the process of obtaining a double bachelors degree in Media & Communications and Business from Swinburne University in Melbourne.

Leave a Reply

Your email address will not be published. Required fields are marked *